 | • レポートコード：MRC23Q36196 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥435,000 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥870,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の間葉系幹細胞/エクソソーム診断/治療市場について調査・分析し、世界の間葉系幹細胞/エクソソーム診断/治療市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（タイプⅠ、タイプⅡ）、用途別セグメント分析（診断、治療、スキンケア）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Tianjin Angsai Cell Genetic Engineering Co. Ltd、Qingdao Aoke Biological Development Co. Ltd、Beijing SH biotechnology Co. Ltd、Beijing Beilai Biotechnology Co. Ltd、Shanghai Aisar Biotechnology Co. Ltd、Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd、Beijing Han's United Biotechnology Co. Ltd、Bosheng Excellence Biotechnology (Beijing) Co. Ltd、Cellular Biomedicine Group、Guangzhou Celera Stem Cell Technology Co. Ltd.、Stem Med Pte Ltd、CryoCord Sdn Bhd、Cytopeutics Sdn Bhd、Stempeutics Research Pvt Ltd、Asian Institute of Gastroenterologyなどが含まれています。 世界の間葉系幹細胞/エクソソーム診断/治療市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、間葉系幹細胞/エクソソーム診断/治療市場規模を推定する際に考慮しました。本レポートは、間葉系幹細胞/エクソソーム診断/治療の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、間葉系幹細胞/エクソソーム診断/治療に関するビジネス上の意思決定に役立てることを目的としています。 ・間葉系幹細胞/エクソソーム診断/治療市場の概要 - 間葉系幹細胞/エクソソーム診断/治療のタイプ別セグメント - 世界の間葉系幹細胞/エクソソーム診断/治療市場規模：タイプ別分析（タイプⅠ、タイプⅡ） - 間葉系幹細胞/エクソソーム診断/治療の用途別セグメント - 世界の間葉系幹細胞/エクソソーム診断/治療市場規模：用途別分析（診断、治療、スキンケア） - 世界の間葉系幹細胞/エクソソーム診断/治療市場規模予測（2018年-2029年） ・間葉系幹細胞/エクソソーム診断/治療市場の成長トレンド - 間葉系幹細胞/エクソソーム診断/治療の地域別市場規模（2018年-2029年） - 間葉系幹細胞/エクソソーム診断/治療市場ダイナミクス - 間葉系幹細胞/エクソソーム診断/治療の業界動向 - 間葉系幹細胞/エクソソーム診断/治療市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：タイプⅠ、タイプⅡ - 世界の間葉系幹細胞/エクソソーム診断/治療のタイプ別市場規模（2018年-2023年） - 世界の間葉系幹細胞/エクソソーム診断/治療のタイプ別市場規模（2024年-2029年） ・用途別セグメント：診断、治療、スキンケア - 世界の間葉系幹細胞/エクソソーム診断/治療の用途別市場規模（2018年-2023年） - 世界の間葉系幹細胞/エクソソーム診断/治療の用途別市場規模（2024年-2029年） ・間葉系幹細胞/エクソソーム診断/治療の地域別市場規模 - 北米の間葉系幹細胞/エクソソーム診断/治療市場規模（2018年-2029年） - アメリカの間葉系幹細胞/エクソソーム診断/治療市場規模（2018年-2029年） - ヨーロッパの間葉系幹細胞/エクソソーム診断/治療市場規模（2018年-2029年） - アジア太平洋の間葉系幹細胞/エクソソーム診断/治療市場規模（2018年-2029年） - 中国の間葉系幹細胞/エクソソーム診断/治療市場規模（2018年-2029年） - 日本の間葉系幹細胞/エクソソーム診断/治療市場規模（2018年-2029年） - 韓国の間葉系幹細胞/エクソソーム診断/治療市場規模（2018年-2029年） - インドの間葉系幹細胞/エクソソーム診断/治療市場規模（2018年-2029年） - オーストラリアの間葉系幹細胞/エクソソーム診断/治療市場規模（2018年-2029年） - 中南米の間葉系幹細胞/エクソソーム診断/治療市場規模（2018年-2029年） - 中東・アフリカの間葉系幹細胞/エクソソーム診断/治療市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Tianjin Angsai Cell Genetic Engineering Co. Ltd、Qingdao Aoke Biological Development Co. Ltd、Beijing SH biotechnology Co. Ltd、Beijing Beilai Biotechnology Co. Ltd、Shanghai Aisar Biotechnology Co. Ltd、Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd、Beijing Han's United Biotechnology Co. Ltd、Bosheng Excellence Biotechnology (Beijing) Co. Ltd、Cellular Biomedicine Group、Guangzhou Celera Stem Cell Technology Co. Ltd.、Stem Med Pte Ltd、CryoCord Sdn Bhd、Cytopeutics Sdn Bhd、Stempeutics Research Pvt Ltd、Asian Institute of Gastroenterology ・アナリストの観点/結論 ・調査方法とデータソース |
Exosomes are a type of vesicles (Extracellular Vesicles, EVs) secreted by cells to the outside of the cell, with a size of 30-150nm, a double-layer membrane structure and a saucer-like shape, and rich contents (including nucleic acids, proteins and lipids, etc.), involved in the transfer of molecules between cells.
As an emerging technology, it has many problems, including accurately encoding and delivering targeted therapeutics, not to mention issues surrounding intellectual property and large-scale manufacturing. For diagnostic applications, products from Exosome Diagnostics are available; for therapeutic applications, although there are three listed companies focusing on exosomes – Capricor, Puretech and Reneuron, none of the company’s products have actually been used in clinical practice.
Highlights
The global Msenchymal Stem Cell and Exosome Diagnostics and Therapies market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Exosome industry in China is in the initial stage of germination and development, The exosome industry in foreign currently has a limited number of players. Geographically speaking, China holds about 80% of total market share.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Msenchymal Stem Cell and Exosome Diagnostics and Therapies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Msenchymal Stem Cell and Exosome Diagnostics and Therapies.
The Msenchymal Stem Cell and Exosome Diagnostics and Therapies market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Msenchymal Stem Cell and Exosome Diagnostics and Therapies market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Msenchymal Stem Cell and Exosome Diagnostics and Therapies companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Tianjin Angsai Cell Genetic Engineering Co. Ltd
Qingdao Aoke Biological Development Co. Ltd
Beijing SH biotechnology Co. Ltd
Beijing Beilai Biotechnology Co. Ltd
Shanghai Aisar Biotechnology Co. Ltd
Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd
Beijing Han’s United Biotechnology Co. Ltd
Bosheng Excellence Biotechnology (Beijing) Co. Ltd
Cellular Biomedicine Group
Guangzhou Celera Stem Cell Technology Co. Ltd.
Stem Med Pte Ltd
CryoCord Sdn Bhd
Cytopeutics Sdn Bhd
Stempeutics Research Pvt Ltd
Asian Institute of Gastroenterology
Segment by Type
Type I
Type II
Segment by Application
Diagnostics
Therapies
Skincare
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Msenchymal Stem Cell and Exosome Diagnostics and Therapies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Type I
1.2.3 Type II
1.3 Market by Application
1.3.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Diagnostics
1.3.3 Therapies
1.3.4 Skincare
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Perspective (2018-2029)
2.2 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Growth Trends by Region
2.2.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Historic Market Size by Region (2018-2023)
2.2.3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Forecasted Market Size by Region (2024-2029)
2.3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Dynamics
2.3.1 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Industry Trends
2.3.2 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Drivers
2.3.3 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Challenges
2.3.4 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Msenchymal Stem Cell and Exosome Diagnostics and Therapies Players by Revenue
3.1.1 Global Top Msenchymal Stem Cell and Exosome Diagnostics and Therapies Players by Revenue (2018-2023)
3.1.2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue Market Share by Players (2018-2023)
3.2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue
3.4 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Concentration Ratio
3.4.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Msenchymal Stem Cell and Exosome Diagnostics and Therapies Revenue in 2022
3.5 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Key Players Head office and Area Served
3.6 Key Players Msenchymal Stem Cell and Exosome Diagnostics and Therapies Product Solution and Service
3.7 Date of Enter into Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Breakdown Data by Type
4.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Historic Market Size by Type (2018-2023)
4.2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Forecasted Market Size by Type (2024-2029)
5 Msenchymal Stem Cell and Exosome Diagnostics and Therapies Breakdown Data by Application
5.1 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Historic Market Size by Application (2018-2023)
5.2 Global Msenchymal Stem Cell and Exosome Diagnostics and Therapies Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size (2018-2029)
6.2 North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2018-2023)
6.4 North America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size (2018-2029)
7.2 Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2018-2023)
7.4 Europe Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size (2018-2029)
8.2 Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Region (2018-2023)
8.4 Asia-Pacific Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size (2018-2029)
9.2 Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2018-2023)
9.4 Latin America Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size (2018-2029)
10.2 Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2018-2023)
10.4 Middle East & Africa Msenchymal Stem Cell and Exosome Diagnostics and Therapies Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Tianjin Angsai Cell Genetic Engineering Co. Ltd
11.1.1 Tianjin Angsai Cell Genetic Engineering Co. Ltd Company Detail
11.1.2 Tianjin Angsai Cell Genetic Engineering Co. Ltd Business Overview
11.1.3 Tianjin Angsai Cell Genetic Engineering Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction
11.1.4 Tianjin Angsai Cell Genetic Engineering Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
11.1.5 Tianjin Angsai Cell Genetic Engineering Co. Ltd Recent Development
11.2 Qingdao Aoke Biological Development Co. Ltd
11.2.1 Qingdao Aoke Biological Development Co. Ltd Company Detail
11.2.2 Qingdao Aoke Biological Development Co. Ltd Business Overview
11.2.3 Qingdao Aoke Biological Development Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction
11.2.4 Qingdao Aoke Biological Development Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
11.2.5 Qingdao Aoke Biological Development Co. Ltd Recent Development
11.3 Beijing SH biotechnology Co. Ltd
11.3.1 Beijing SH biotechnology Co. Ltd Company Detail
11.3.2 Beijing SH biotechnology Co. Ltd Business Overview
11.3.3 Beijing SH biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction
11.3.4 Beijing SH biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
11.3.5 Beijing SH biotechnology Co. Ltd Recent Development
11.4 Beijing Beilai Biotechnology Co. Ltd
11.4.1 Beijing Beilai Biotechnology Co. Ltd Company Detail
11.4.2 Beijing Beilai Biotechnology Co. Ltd Business Overview
11.4.3 Beijing Beilai Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction
11.4.4 Beijing Beilai Biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
11.4.5 Beijing Beilai Biotechnology Co. Ltd Recent Development
11.5 Shanghai Aisar Biotechnology Co. Ltd
11.5.1 Shanghai Aisar Biotechnology Co. Ltd Company Detail
11.5.2 Shanghai Aisar Biotechnology Co. Ltd Business Overview
11.5.3 Shanghai Aisar Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction
11.5.4 Shanghai Aisar Biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
11.5.5 Shanghai Aisar Biotechnology Co. Ltd Recent Development
11.6 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd
11.6.1 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Company Detail
11.6.2 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Business Overview
11.6.3 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction
11.6.4 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
11.6.5 Jiuzhitang Meike (Beijing) Cell Technology Co. Ltd Recent Development
11.7 Beijing Han’s United Biotechnology Co. Ltd
11.7.1 Beijing Han’s United Biotechnology Co. Ltd Company Detail
11.7.2 Beijing Han’s United Biotechnology Co. Ltd Business Overview
11.7.3 Beijing Han’s United Biotechnology Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction
11.7.4 Beijing Han’s United Biotechnology Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
11.7.5 Beijing Han’s United Biotechnology Co. Ltd Recent Development
11.8 Bosheng Excellence Biotechnology (Beijing) Co. Ltd
11.8.1 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Company Detail
11.8.2 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Business Overview
11.8.3 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction
11.8.4 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
11.8.5 Bosheng Excellence Biotechnology (Beijing) Co. Ltd Recent Development
11.9 Cellular Biomedicine Group
11.9.1 Cellular Biomedicine Group Company Detail
11.9.2 Cellular Biomedicine Group Business Overview
11.9.3 Cellular Biomedicine Group Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction
11.9.4 Cellular Biomedicine Group Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
11.9.5 Cellular Biomedicine Group Recent Development
11.10 Guangzhou Celera Stem Cell Technology Co. Ltd.
11.10.1 Guangzhou Celera Stem Cell Technology Co. Ltd. Company Detail
11.10.2 Guangzhou Celera Stem Cell Technology Co. Ltd. Business Overview
11.10.3 Guangzhou Celera Stem Cell Technology Co. Ltd. Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction
11.10.4 Guangzhou Celera Stem Cell Technology Co. Ltd. Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
11.10.5 Guangzhou Celera Stem Cell Technology Co. Ltd. Recent Development
11.11 Stem Med Pte Ltd
11.11.1 Stem Med Pte Ltd Company Detail
11.11.2 Stem Med Pte Ltd Business Overview
11.11.3 Stem Med Pte Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction
11.11.4 Stem Med Pte Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
11.11.5 Stem Med Pte Ltd Recent Development
11.12 CryoCord Sdn Bhd
11.12.1 CryoCord Sdn Bhd Company Detail
11.12.2 CryoCord Sdn Bhd Business Overview
11.12.3 CryoCord Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction
11.12.4 CryoCord Sdn Bhd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
11.12.5 CryoCord Sdn Bhd Recent Development
11.13 Cytopeutics Sdn Bhd
11.13.1 Cytopeutics Sdn Bhd Company Detail
11.13.2 Cytopeutics Sdn Bhd Business Overview
11.13.3 Cytopeutics Sdn Bhd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction
11.13.4 Cytopeutics Sdn Bhd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
11.13.5 Cytopeutics Sdn Bhd Recent Development
11.14 Stempeutics Research Pvt Ltd
11.14.1 Stempeutics Research Pvt Ltd Company Detail
11.14.2 Stempeutics Research Pvt Ltd Business Overview
11.14.3 Stempeutics Research Pvt Ltd Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction
11.14.4 Stempeutics Research Pvt Ltd Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
11.14.5 Stempeutics Research Pvt Ltd Recent Development
11.15 Asian Institute of Gastroenterology
11.15.1 Asian Institute of Gastroenterology Company Detail
11.15.2 Asian Institute of Gastroenterology Business Overview
11.15.3 Asian Institute of Gastroenterology Msenchymal Stem Cell and Exosome Diagnostics and Therapies Introduction
11.15.4 Asian Institute of Gastroenterology Revenue in Msenchymal Stem Cell and Exosome Diagnostics and Therapies Business (2018-2023)
11.15.5 Asian Institute of Gastroenterology Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details